A key factor driving the growth of the market is the increasing incidence of cancer. Cancer changes the morphology of human cells, as it leads to uncontrolled division of cells that results from a combination of both environmental and hereditary risk factors. There are more than 80 types of cancer, which have a major impact on the health and well being of individuals across the globe. Cancer is one of the leading causes of morbidity globally. In 2017, approximately 16 million new cases of cancer were reported, and the number is expected to increase by 2023. Such rising incidences of cancer drive the demand for liquid biopsy as it helps in detecting genetic changes in the tumor.
This market research report on the global liquid biopsy market 2018-2022 also provides an analysis of the most important trends expected to impact the market outlook during the forecast period. Technavio classifies an emerging trend as a major factor that has the potential to significantly impact the market and contribute to its growth or decline.
This report is available at a USD 1,000 discount for a limited time only: View market snapshot before purchasing
In this report, Technavio highlights the increasing funding or investment for liquid biopsy as one of the key emerging trends in the global liquid biopsy procedure market:
Global liquid biopsy market: Increasing funding or investment for liquid biopsy
Liquid biopsy gained momentum in the last few years, both as a research tool and as a sophisticated diagnostic technology. Hence, the market attracted investors for funding and R&D of new technologies, and development and commercialization of liquid biopsy products.
“Some of the major vendors in the liquid biopsy market received funding from various investors. Recently, Guardant Health, one of the leading vendors secured USD 360 million in new funding led by SoftBank Group along with other investors,” says a senior analyst at Technavio for research on human machine interface.
Global liquid biopsy market: Segmentation analysis
This market research report segments the global liquid biopsy market by technology (CTC and ctDNA, and exosome and RNA) and geographical regions (APAC, EMEA, and the Americas).
The Americas led the market in 2017 with a market share of close to 57%, followed by EMEA and APAC respectively. However, APAC is expected to witness faster growth rate compared with the Americas and EMEA.
Looking for more information on this market? Request a free sample report
Technavio’s sample reports are free of charge and contain multiple sections of the report such as the market size and forecast, drivers, challenges, trends, and more.
Some of the key topics covered in the report include:
- Market ecosystem
- Market characteristics
- Market segmentation analysis
- Market sizing
- Market size and forecast
Five Forces Analysis
- Regional comparison
- Key leading countries
- Vendors covered
- Vendor classification
- Market positioning of vendors
- Competitive scenario
Technavio is a leading global technology research and advisory company. Their research and analysis focuses on emerging market trends and provides actionable insights to help businesses identify market opportunities and develop effective strategies to optimize their market positions.
With over 500 specialized analysts, Technavio’s report library consists of more than 10,000 reports and counting, covering 800 technologies, spanning across 50 countries. Their client base consists of enterprises of all sizes, including more than 100 Fortune 500 companies. This growing client base relies on Technavio’s comprehensive coverage, extensive research, and actionable market insights to identify opportunities in existing and potential markets and assess their competitive positions within changing market scenarios.
If you are interested in more information, please contact our media team at firstname.lastname@example.org.